citalopram has been researched along with Neoplasms in 10 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"We undertook an open-label pilot study using citalopram in 30 cancer patients who reported a high level of depressive symptoms on the Zung Self-Rating Depression Scale (ZSDS)." | 9.10 | An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients. ( Donaghy, K; Holtsclaw, E; Kirsh, KL; Passik, SD; Theobald, DE, 2003) |
"6 years), predominantly female with non-metastatic breast, lung and colon cancer and depressive disorder (DSM-IV-TR) were randomized to receive treatment with NT plus escitalopram (n=39) or escitalopram (10-20 mg QD) plus usual care (n=33)." | 5.15 | Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial. ( Bayón, C; Benito, G; Castelo, B; Dieguez, M; Hospital, A; Palao, A; Pérez, E; Rodríguez Vega, B; Torres, G, 2011) |
"We undertook an open-label pilot study using citalopram in 30 cancer patients who reported a high level of depressive symptoms on the Zung Self-Rating Depression Scale (ZSDS)." | 5.10 | An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients. ( Donaghy, K; Holtsclaw, E; Kirsh, KL; Passik, SD; Theobald, DE, 2003) |
"One hundred sixty-five patients with cancer, consecutively admitted to the Oncology Division of San Camillo-Forlanini Hospital, were recruited to the study." | 1.33 | Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. ( Biondi, M; Cairoli, F; Costantini, A; Ferrarese, G; Pasquini, M; Picardi, A; Sternberg, C, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Taler, M | 1 |
Gil-Ad, I | 1 |
Brener, I | 1 |
Hornfeld, SH | 1 |
Weizman, A | 1 |
Raddin, RS | 1 |
Park, EM | 1 |
Hamer, RM | 1 |
Nelson, KM | 1 |
Mayer, DK | 1 |
Rosenstein, DL | 1 |
Bernard, SA | 1 |
Rodríguez Vega, B | 2 |
Palao, A | 2 |
Torres, G | 2 |
Hospital, A | 2 |
Benito, G | 2 |
Pérez, E | 1 |
Dieguez, M | 2 |
Castelo, B | 1 |
Bayón, C | 2 |
Franco, CC | 1 |
Castro-Prado, J | 1 |
Rosada, LJ | 1 |
Sant'Anna, JR | 1 |
Castro-Prado, MA | 1 |
Orgaz Barnier, P | 1 |
Fernández Liria, A | 1 |
Labos, C | 1 |
Dasgupta, K | 1 |
Nedjar, H | 1 |
Turecki, G | 1 |
Rahme, E | 1 |
Theobald, DE | 1 |
Kirsh, KL | 1 |
Holtsclaw, E | 1 |
Donaghy, K | 1 |
Passik, SD | 1 |
Balon, R | 1 |
Pasquini, M | 1 |
Biondi, M | 1 |
Costantini, A | 1 |
Cairoli, F | 1 |
Ferrarese, G | 1 |
Picardi, A | 1 |
Sternberg, C | 1 |
Granet, R | 1 |
Sutter, S | 1 |
1 review available for citalopram and Neoplasms
Article | Year |
---|---|
Mood, anxiety, and physical illness: body and mind, or mind and body?
Topics: Anxiety Disorders; Autoimmune Diseases; Citalopram; Comorbidity; Health Status; Heart Diseases; Huma | 2006 |
3 trials available for citalopram and Neoplasms
Article | Year |
---|---|
Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Combined Modality The | 2011 |
Differences in depressed oncologic patients' narratives after receiving two different therapeutic interventions for depression: a qualitative study.
Topics: Adaptation, Psychological; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Combin | 2012 |
An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents, Second-Generation; Bore | 2003 |
6 other studies available for citalopram and Neoplasms
Article | Year |
---|---|
Complex Effects of Sertraline and Citalopram on In Vitro Murine Breast Cancer Proliferation and on In Vivo Progression and Anxiety Level.
Topics: Animals; Anxiety; Cell Proliferation; Citalopram; Mice; Neoplasms; Selective Serotonin Reuptake Inhi | 2022 |
A pilot study to evaluate symptom-oriented selection of antidepressants in patients with cancer.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive D | 2014 |
Mitotic recombination: a genotoxic effect of the antidepressant citalopram in Aspergillus nidulans.
Topics: Antidepressive Agents, Second-Generation; Aspergillus nidulans; Carcinogens; Citalopram; Crossing Ov | 2010 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Ag | 2011 |
Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Citalopram; Depressive D | 2006 |
Can chemotherapy induce reactions of recollection?
Topics: Antidepressive Agents; Antineoplastic Agents; Breast Neoplasms; Citalopram; Depressive Disorder; Fem | 2007 |